NEW PERSPECTIVES IN THE DIAGNOSIS AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

Myogenesis modelled by human pluripotent stem cells: a multi-omic study of Duchenne myopathy early onset

As provider of the bulk and single-cell RNA-seq libraries and sequencing, IntegraGen is proud of sharing this new publication.

Background

Duchenne Muscular Dystrophy (DMD) is a rare disease characterized by early muscular damages. The earlier the disease is diagnosed the earlier patients can access standards of care, genetic counselling and clinical trials.

Results

Christian Pinset, Virginie Mournetas et al. have modelized the skeletal myogenesis process with human tissue-derived myoblasts and human induced pluripotent stem cells (hiPSCs) from Duchenne Muscular Dystrophy patients. Based on multi-omics analysis strategy combining transcriptomic, miRnome and proteomic exploration, the scientists identified significant transcriptomic dysregulation starting at the somite stage, an early developmental stage.

Conclusion

These discoveries open new perspectives for early diagnosis of the DMD disease and also potential new targets for drugs development.

Leave a Reply

Your email address will not be published. Required fields are marked *

en_US